Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults.

Cobo-Calvo A, Vukusic S, Marignier R.

Curr Opin Neurol. 2019 Feb 11. doi: 10.1097/WCO.0000000000000681. [Epub ahead of print]

PMID:
30762607
2.

Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Cobo-Calvo A, Sepúlveda M, d'Indy H, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Montcuquet A, Deschamps R, Solà-Valls N, Llufriu S, Blanco Y, de Seze J, Vukusic S, Saiz A, Marignier R; OFSEP Group; REEM Group.

J Neurol. 2019 Feb 7. doi: 10.1007/s00415-019-09215-1. [Epub ahead of print]

PMID:
30759286
3.

Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Cobo-Calvo A, Sepúlveda M, d'Indy H, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Montcuquet A, Deschamps R, Solà-Valls N, Llufriu S, Blanco Y, de Seze J, Vukusic S, Saiz A, Marignier R; OFSEP Group; REEM Group.

J Neurol. 2019 Jan 3. doi: 10.1007/s00415-018-9160-9. [Epub ahead of print] Erratum in: J Neurol. 2019 Feb 7;:.

PMID:
30607536
4.

Feasibility and Effects of Structured Physical Exercise Interventions in Adults with Relapsing-Remitting Multiple Sclerosis: A Pilot Study.

Guillamó E, Cobo-Calvo Á, Oviedo GR, Travier N, Álamo J, Niño-Mendez OA, Martínez-Yelamos A, Martínez-Yelamos S, Javierre C.

J Sports Sci Med. 2018 Aug 14;17(3):426-436. eCollection 2018 Sep.

5.

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group.

Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.

PMID:
29695592
6.

MOG antibody-related disorders: common features and uncommon presentations.

Cobo-Calvo Á, Ruiz A, D'Indy H, Poulat AL, Carneiro M, Philippe N, Durand-Dubief F, Deiva K, Vukusic S, Desportes V, Marignier R.

J Neurol. 2017 Sep;264(9):1945-1955. doi: 10.1007/s00415-017-8583-z. Epub 2017 Aug 2.

PMID:
28770374
7.

Neuromyelitis optica and neuromyelitis optica spectrum disorders.

Marignier R, Cobo Calvo A, Vukusic S.

Curr Opin Neurol. 2017 Jun;30(3):208-215. doi: 10.1097/WCO.0000000000000455. Review.

PMID:
28306572
8.

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.

Mañé-Martínez MA, Olsson B, Bau L, Matas E, Cobo-Calvo Á, Andreasson U, Blennow K, Romero-Pinel L, Martínez-Yélamos S, Zetterberg H.

J Neuroimmunol. 2016 Oct 15;299:112-117. doi: 10.1016/j.jneuroim.2016.08.004. Epub 2016 Aug 24.

PMID:
27725108
9.

Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.

Cobo-Calvo Á, Figueras A, Bau L, Matas E, Mañé Martínez MA, León I, Majòs C, Romero-Pinel L, Martínez-Yélamos S.

Clin Immunol. 2016 Oct;171:18-24. doi: 10.1016/j.clim.2016.08.003. Epub 2016 Aug 3.

PMID:
27496090
10.

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.

Sepúlveda M, Armangué T, Sola-Valls N, Arrambide G, Meca-Lallana JE, Oreja-Guevara C, Mendibe M, Alvarez de Arcaya A, Aladro Y, Casanova B, Olascoaga J, Jiménez-Huete A, Fernández-Fournier M, Ramió-Torrentà L, Cobo-Calvo A, Viñals M, de Andrés C, Meca-Lallana V, Cervelló A, Calles C, Rubio MB, Ramo-Tello C, Caminero A, Munteis E, Antigüedad AR, Blanco Y, Villoslada P, Montalban X, Graus F, Saiz A.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 14;3(3):e225. doi: 10.1212/NXI.0000000000000225. eCollection 2016 Jun.

11.

MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.

Matas E, Bau L, Martínez-Iniesta M, Romero-Pinel L, Mañé-Martínez MA, Cobo-Calvo Á, Martínez-Yélamos S.

J Neuroimmunol. 2016 Feb 15;291:73-7. doi: 10.1016/j.jneuroim.2015.12.015. Epub 2015 Dec 30.

PMID:
26857498
12.

Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.

Martínez-Rodríguez JE, Cobo-Calvo A, Villar LM, Munteis E, Blanco Y, Rasal R, Vera A, Muntasell A, Alvarez-Lafuente R, Saiz A, Alvarez-Cermeño JC, Martínez-Yélamos S, Roquer J, López-Botet M.

Mult Scler. 2016 May;22(6):741-52. doi: 10.1177/1352458515601215. Epub 2015 Sep 11.

PMID:
26362897
13.

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.

Cobo-Calvo Á, Sepúlveda M, Bernard-Valnet R, Ruiz A, Brassat D, Martínez-Yélamos S, Saiz A, Marignier R.

Mult Scler. 2016 Mar;22(3):312-9. doi: 10.1177/1352458515591071. Epub 2015 Jul 24.

PMID:
26209592
14.

Effectiveness of natalizumab in patients with highly active relapsing remitting multiple sclerosis.

Cobo-Calvo Á, Bau L, Matas E, Romero-Pinel L, Mañé Martínez MA, Majós C, Martínez Yélamos S.

Eur Neurol. 2015;73(3-4):220-9. doi: 10.1159/000375371. Epub 2015 Mar 13.

PMID:
25792347
15.

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.

Martínez MA, Olsson B, Bau L, Matas E, Cobo Calvo Á, Andreasson U, Blennow K, Romero-Pinel L, Martínez-Yélamos S, Zetterberg H.

Mult Scler. 2015 Apr;21(5):550-61. doi: 10.1177/1352458514549397. Epub 2015 Mar 2.

16.

Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients.

Matas E, Bau L, Martínez-Iniesta M, Romero-Pinel L, Mañé MA, Cobo-Calvo Á, Martínez-Yélamos S.

PLoS One. 2014 Nov 14;9(11):e112758. doi: 10.1371/journal.pone.0112758. eCollection 2014.

17.

Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies.

Cobo-Calvo Á, Alentorn A, Mañé Martínez MA, Bau L, Matas E, Bruna J, Romero-Pinel L, Martínez-Yélamos S.

Eur Neurol. 2014;72(1-2):86-94. doi: 10.1159/000358512. Epub 2014 Jun 14.

PMID:
24942967
18.

Optic neuritis in the setting of NMDA receptor encephalitis.

Cobo-Calvo A, Izquierdo Gracia C, Quiñones SM, Torro CM, Saiz A, Dalmau J, Martínez-Yélamos S.

J Neuroophthalmol. 2014 Sep;34(3):316-9. doi: 10.1097/WNO.0000000000000140. No abstract available.

PMID:
24905275
19.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J.

Ann Neurol. 2014 Mar;75(3):411-28.

20.

Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.

Cobo Calvo A, Mañé Martínez MA, Alentorn-Palau A, Bruna Escuer J, Romero Pinel L, Martínez-Yélamos S.

BMC Neurol. 2013 Oct 3;13:135. doi: 10.1186/1471-2377-13-135.

21.

[False-negative polymerase chain reaction test in cerebrospinal fluid in herpes simplex encephalitis].

Cobo Calvo A, Riera-Mestre A, Niubo Bosch J, Martínez-Yélamos S.

Med Clin (Barc). 2012 Nov 3;139(11):511-2. doi: 10.1016/j.medcli.2012.03.003. Epub 2012 Apr 24. Spanish. No abstract available.

PMID:
22534453
22.

Myasthenia gravis exacerbation after cetirizine administration.

Cobo Calvo A, Albertí Aguiló MA, Casasnovas Pons C.

Muscle Nerve. 2011 Jul;44(1):146-7. doi: 10.1002/mus.22096. No abstract available.

PMID:
21674530
23.

[Bilateral trigeminal neuropathy in neurosarcoidosis: clinical, radiological and neurophysiological distinctive findings].

Cobo Calvo A, Veciana de Las Heras M, Vidaller Palacín A, Martínez-Yélamos S.

Med Clin (Barc). 2011 Jun 11;137(1):44-5. doi: 10.1016/j.medcli.2010.07.013. Epub 2010 Nov 5. Spanish. No abstract available.

PMID:
21056432

Supplemental Content

Loading ...
Support Center